Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Brain Neoplasms 3Carcinoma, Hepatocellular 2Prostatic Neoplasms 1Pinealoma 1Oligodendroglioma 1Neuroectodermal Tumors, Primitive 1Multiple Sclerosis 1Meningioma 1Medulloblastoma 1Lymphoma 1Liver Neoplasms 1Gliosarcoma 1Glioma 1Glioblastoma 1Ependymoma 1Colorectal Neoplasms 1Choroid Plexus Neoplasms 1Breast Neoplasms 1Astrocytoma 1

Interventions

Cyclophosphamide 9Temozolomide 7Radiotherapy 6Magnetic Resonance Spectroscopy 5Filgrastim 5Cisplatin 5Carboplatin 5antineoplaston AS 2-1 4antineoplaston A10 4Etoposide 4sargramostim 3Vincristine 3Thiotepa 3Melphalan 3Automobiles 3fludarabine 2aldesleukin 2Thalidomide 2Surveys and Questionnaires 2Granulocyte Colony-Stimulating Factor 2Gemcitabine 2Gadolinium DTPA 2Eflornithine 2Donepezil 2Carmustine 2Biopsy 22-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 2trifluridine tipiracil drug combination 1trametinib 1thymoglobulin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Neuroectodermal Tumors, Primitive × gadobenic acid × Clear all
NCT02967380 2017-03-27

Gadobutrol Versus Gadopentetate Dimeglumine or Gadobenate Dimeglumine Before DCE-MRI in Diagnosing Patients With Multiple Sclerosis, Grade II-IV Glioma, or Brain Metastases

University of Southern California

Phase NA Terminated
14 enrolled
CNSSarcoma

Astrocytoma, Brain Neoplasms, Ependymoma, Glioblastoma, Glioma, Medulloblastoma, Meningioma, Multiple Sclerosis, Oligodendroglioma, Pinealoma, Choroid Plexus Neoplasms, Neuroectodermal Tumors, Primitive, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡